Home >> IT Services >> Apparel >> Heavy Industry >>

Global Human Growth Hormone Market 2015-2019

Published: Nov-2014 | Format: PDF | Technavio | Number of pages: 87 | Code: MRS - 1826

 

Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities.

TechNavio's analysts forecast the Global Human Growth Hormone market to grow at a  CAGR of 4.22 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Human Growth Hormone market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of innovator human growth hormone drugs and their technologies.

TechNavio's report, Global Human Growth Hormone Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Growth Hormone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
Americas
APAC
EMEA

Key Vendors
F. Hoffmann-La Roche
Merck Serono
Novo Nordisk
Pfizer

Other Prominent Vendors
Anhui Anke Biotechnology (Group)
BioPartners
Eli Lilly
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Teva Pharmaceutical Industries

Market Driver
Increased Demand for Human Growth Hormones
For a full, detailed list, view our report

Market Challenge
Intense Market Competition
For a full, detailed list, view our report

Market Trend
Advances in Technology
For a full, detailed list, view our report

Table of Contents


1. Executive Summary


2. List of Abbreviations

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

5. Introduction

6. Human Growth Hormone
6.1.1 Introduction
6.1.2 Human Growth Hormone
6.1.3 Mechanism of Action
6.1.4 Growth Hormone Levels
6.1.5 Population Group
6.1.6 Growth Hormone Levels (ng/mL)
6.1.7 Growth Hormone Deficiency

7. Market Landscape
7.1 Market Overview
7.2 Market Size and Forecast
7.3 Five Forces Analysis

8. Geographical Segmentation
8.1 Human Growth Hormone Market in Americas
8.1.1 Market Size and Forecast
8.2 Human Growth Hormone Market in EMEA Region
8.2.1 Market Size and Forecast
8.3 Human Growth Hormone Market in APAC Region
8.3.1 Market Size and Forecast

9. Key Leading Countries
9.1 US
9.2 Japan
9.3 Germany
9.4 Italy

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Merck Serono
17.2.2 Pfizer
17.2.3 Novo Nordisk
17.2.4 F. Hoffmann-La Roche
17.3 Other Prominent Vendors

18. Key Vendor Analysis
18.1 F. Hoffmann-La Roche
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Merck Serono
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Geographical Segmentation by Revenue 2013
18.2.4 Business Strategy
18.2.5 Recent Developments
18.2.6 SWOT Analysis
18.3 Novo Nordisk
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.4 Pfizer
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue
18.4.6 Business Strategy
18.4.7 Key Developments
18.4.8 SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: 3D Structure of Human Growth Hormone
Exhibit 3: UniProt Details for Human Growth Hormone
Exhibit 4: Regulation of Human Growth Hormone Secretion
Exhibit 5: Normal Growth Hormone Levels
Exhibit 6: Classification of Growth Hormone Deficiency by Age of Onset
Exhibit 7: Global Human Growth Hormone market 2014-2019 (US$ million)
Exhibit 8: NordiPenMate
Exhibit 9: Global Human Growth Hormone Market Segmentation by Geography 2014
Exhibit 10: Global Human Growth Hormone Market Segmentation by Geography 2019
Exhibit 11: Global Human Growth Hormone Market by Geography 2014-2019 (US$ million)
Exhibit 12: Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 13: Global Human Growth Hormone Market Segmentation by Geography 2014-2019
Exhibit 14: YoY Growth Rate of Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 15: Percentage Share of Global Human Growth Hormone Market by Geography 2014 and 2019
Exhibit 16: Human Growth Hormone Market in the Americas 2014-2019 (US$ million)
Exhibit 17: Human Growth Hormone Market in the EMEA Region 2014-2019 (US$ million)
Exhibit 18: Human Growth Hormone Market in the APAC Region 2014-2019 (US$ million)
Exhibit 19: NovoFine Needle
Exhibit 20: Market Share Comparison of Major Drugs 2014 H1
Exhibit 21: Parts of Click.easy
Exhibit 22: Easypod Drug Delivery Device
Exhibit 23: Parts of Cool.click 2
Exhibit 24: One.click Drug Delivery Device
Exhibit 25: Serojet Drug Delivery Device
Exhibit 26: Genotropin Miniquick
Exhibit 27: Parts of Genotropin Miniquick
Exhibit 28: Genotropin Mixer
Exhibit 29: Parts of Genotropin Mixer
Exhibit 30: Genotropin Pen
Exhibit 31: Parts of Genotropin Pen
Exhibit 32: Dosage Strengths of FlexPro
Exhibit 33: Dosage Strengths of NordiFlex
Exhibit 34: Dosage Strengths of Norditropin NordiLet
Exhibit 35: Dosage Strengths of Nordipen
Exhibit 36: Parts of Nordipen
Exhibit 37: Parts of Nutropin AQ NuSpin
Exhibit 38: Nutropin AQ NuSpin 20
Exhibit 39: Nutropin AQ NuSpin 10
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 43: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 44: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 45: Novo Nordisk A/S: Business Segmentation by Revenue 2013
Exhibit 46: Novo Nordisk A/S: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 47: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 48: Pfizer: Business Segmentation by Revenue 2013
Exhibit 49: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 50: Pfizer: Geographical Segmentation by Revenue 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing